Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pooja Hingorani

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Future Oncology (London, England)|April 9, 2010
Past, present and future of therapies in pediatric sarcomasPooja Hingorani, Edward A Kolb
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Emerging molecular-targeted therapies in early-phase clinical trials and preclinical modelsMichael Ferguson, Pooja Hingorani, Abha A Gupta
Journal of Cancer Epidemiology|November 29, 2014
Incidence and outcomes of desmoplastic small round cell tumor: results from the surveillance, epidemiology, and end results databaseChristina K Lettieri, Pamela Garcia-Filion, Pooja Hingorani
Expert Review of Anticancer Therapy|February 10, 2012
Progress of oncolytic viruses in sarcomasChristina K Lettieri, Pooja Hingorani, E Anders Kolb
Diabetes Care|September 30, 2008
Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population: the MONICA/KORA Augsburg Cohort Study: response to Ziegler et alVaibhav Salvi, Pooja Hingorani, Arumugam Ramasamy, et al.
Advances in Experimental Medicine and Biology|June 3, 2020
HER2-Targeted Therapy in OsteosarcomaJonathan Gill, Pooja Hingorani, Michael Roth, et al.
Advances in Experimental Medicine and Biology|June 3, 2020
Relapsed Osteosarcoma Trial Concepts to Match the Complexity of the DiseaseDamon R Reed, Pooja Hingorani, Peter M Anderson
Journal of Pediatric Hematology/Oncology|September 11, 2018
Disialoganglioside GD2 Expression in Pediatric Rhabdomyosarcoma: A Case Series and Review of the LiteratureAmanda J Saraf, Paul S Dickman, Pooja Hingorani
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2009
Inhibition of Src phosphorylation alters metastatic potential of osteosarcoma in vitro but not in vivoPooja Hingorani, Wendong Zhang, Richard Gorlick, et al.
Journal of Pediatric Hematology/Oncology|September 26, 2012
Gemcitabine, docetaxel, and bevacizumab in relapsed and refractory pediatric sarcomasPooja Hingorani, Francis Eshun, Andrea White-Collins, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Future Oncology (London, England)|April 9, 2010
Past, present and future of therapies in pediatric sarcomasPooja Hingorani, Edward A Kolb
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Emerging molecular-targeted therapies in early-phase clinical trials and preclinical modelsMichael Ferguson, Pooja Hingorani, Abha A Gupta
Journal of Cancer Epidemiology|November 29, 2014
Incidence and outcomes of desmoplastic small round cell tumor: results from the surveillance, epidemiology, and end results databaseChristina K Lettieri, Pamela Garcia-Filion, Pooja Hingorani
Expert Review of Anticancer Therapy|February 10, 2012
Progress of oncolytic viruses in sarcomasChristina K Lettieri, Pooja Hingorani, E Anders Kolb
Diabetes Care|September 30, 2008
Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population: the MONICA/KORA Augsburg Cohort Study: response to Ziegler et alVaibhav Salvi, Pooja Hingorani, Arumugam Ramasamy, et al.
Advances in Experimental Medicine and Biology|June 3, 2020
HER2-Targeted Therapy in OsteosarcomaJonathan Gill, Pooja Hingorani, Michael Roth, et al.
Advances in Experimental Medicine and Biology|June 3, 2020
Relapsed Osteosarcoma Trial Concepts to Match the Complexity of the DiseaseDamon R Reed, Pooja Hingorani, Peter M Anderson
Journal of Pediatric Hematology/Oncology|September 11, 2018
Disialoganglioside GD2 Expression in Pediatric Rhabdomyosarcoma: A Case Series and Review of the LiteratureAmanda J Saraf, Paul S Dickman, Pooja Hingorani
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2009
Inhibition of Src phosphorylation alters metastatic potential of osteosarcoma in vitro but not in vivoPooja Hingorani, Wendong Zhang, Richard Gorlick, et al.
Journal of Pediatric Hematology/Oncology|September 26, 2012
Gemcitabine, docetaxel, and bevacizumab in relapsed and refractory pediatric sarcomasPooja Hingorani, Francis Eshun, Andrea White-Collins, et al.
Pageof 7